menu close
www.freenome.com
Freenome-Logo

Freenome Stock

Company Profile:

Freenome is a health technology company using accurate, accessible and non-invasive disease screenings to proactively treat cancer and other diseases at their most manageable stages. Freenome does this through a fusion of machine learning, biology and computer science.

Sign up for SecondMarket™ to view the market and buy or sell Freenome Stock
Buy + Sell

Freenome Funding

Sign up to gain insights into Freenome funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Jan 11, 2022 Series E 290.00M
Price
Valuation
Nov 22, 2021 Series D 243.00M
Price
Valuation
Aug 14, 2020 Series C 270.00M
Price
Valuation
Jun 24, 2019 Series B 160.00M
Price
Valuation
Aug 14, 2017 Series A 8.05M
Price
Valuation
Feb 23, 2017 Series A 63.95M
Price
Valuation
May 23, 2016 Series Seed 5.55M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Freenome Management Team

  • Co-Founder, Chief Growth Officer

    Charles Roberts

  • Director

    Randal Scott

  • Co-Founder, COO, Director

    Riley Ennis

  • Director

    Peter Kolchinsky

  • Chief Scientific Officer

    Jimmy Lin

  • CEO, Director

    Mike Nolan

  • Co-Founder, Director

    Gabriel Otte

  • Director

    Amir Nashat

  • Director

    Ellen Hukkelhoven

  • Director

    Vijay Pande

Freenome Major Investors

  • Andreessen Horowitz LLC; AKA: A16Z

  • Catalio Capital Management, LP

  • Charles River Ventures (CRV)

  • Third Kind Venture Capital

  • Section 32

  • Google Ventures (GV)

  • Rock Springs Capital

  • Novartis, Inc.

  • Cormorant Asset Management

  • Bain Capital Venture Partners LLC

  • Artis Ventures

  • Colorectal Cancer Alliance

  • DCVC

  • Ridgeback Capital

  • T. Rowe Price Associates, Inc.

  • BrightEdge

  • Verily Life Sciences LLC

  • Kaiser Permanente Ventures

  • Roche Venture Fund

  • Spectrum 28 Capital

  • Polaris Partners

  • Asset Management Ventures

  • Innovation Endeavors LLC

  • Andreessen Horowitz LLC; AKA: A16Z

  • RA Capital Management LLC

  • Janus Henderson

  • The Founders Fund

  • Bain Capital Venture Partners LLC

  • Soleus Capital Management

  • Farallon Capital Management LLC

  • Catalio Capital Management, LP

  • Cormorant Capital

  • Fidelity Management & Research Company

  • Data Collective

  • F. Hoffmann-La Roche AG

  • Global Venture Capital, Inc.

  • Perceptive Advisors, LLC

  • Sands Capital Management LLC

  • EcoR1 Capital

Learn More About Freenome Stock

Buy Freenome Stock
01

Freenome stock does not trade on public stock exchanges. Freenome stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Freenome stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Freenome Stock
02

Freenome Stock does not trade on public stock exchanges. In order to sell Freenome shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Freenome Stock Price
03

Freenome does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Freenome share price and other valuable private market data.

Read more about secondary market private company stock prices:

Freenome Stock Ticker Symbol
04

There is no ticker symbol for Freenome stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Freenome Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Freenome stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Freenome Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Freenome stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Freenome Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Freenome IPO
08

Freenome is a private company and has not had an IPO. There is currently no Freenome IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Freenome IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Freenome Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Cedar Inc-Logo

Cedar

The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

Devoted-Logo

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Blackrock Neurotech

Neurotechnology company providing brain-computer interface solutions.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Hinge Health-Logo

Hinge Health

Digital clinic for back, joint, and muscle pain.

Somatus-Logo

Somatus

integrated care for patients with or at risk of developing kidney disease.

Imperativecare-Logo

Imperative Care

Advanced medical technology solutions for stroke care.

Heartflow Inc-Logo

Heartflow

Develops non-invasive solutions to assess significant coronary artery disease.

Peek Travel Inc-Logo

Nomi Health

Direct healthcare system that simplifies access to high-quality, affordable care for communities.

Source: Nasdaq Private Market Tape D™